227 related articles for article (PubMed ID: 36804163)
1. Salivary Lactate Dehydrogenase as a Potential Biomarker in Oral Potentially Malignant Disorders and Head & Neck Cancer- A Systematic Review and Meta-analysis.
S LK; Naik Z; Lagali-Jirge V; M S; Panwar A; Keluskar V
Gulf J Oncolog; 2023 Jan; 1(41):78-99. PubMed ID: 36804163
[TBL] [Abstract][Full Text] [Related]
2. Salivary LDH in oral cancer and potentially malignant disorders: A systematic review and meta-analysis.
Iglesias-Velázquez Ó; López-Pintor RM; González-Serrano J; Casañas E; Torres J; Hernández G
Oral Dis; 2022 Jan; 28(1):44-56. PubMed ID: 32881152
[TBL] [Abstract][Full Text] [Related]
3. Lactate dehydrogenase as a biomarker in oral cancer and oral submucous fibrosis.
Kallalli BN; Rawson K; Muzammil ; Singh A; Awati MA; Shivhare P
J Oral Pathol Med; 2016 Oct; 45(9):687-690. PubMed ID: 27132033
[TBL] [Abstract][Full Text] [Related]
4. Salivary cytokines as biomarkers of oral cancer: a systematic review and meta-analysis.
Chiamulera MMA; Zancan CB; Remor AP; Cordeiro MF; Gleber-Netto FO; Baptistella AR
BMC Cancer; 2021 Feb; 21(1):205. PubMed ID: 33639868
[TBL] [Abstract][Full Text] [Related]
5. Assessment of lactate dehydrogenase enzyme levels in saliva and serum of oral submucous fibrosis and leukoplakia patients.
Panda A; Behura SS; Bhuyan L; Dash KC; Kumar V; Mukherjee S
J Oral Maxillofac Pathol; 2020; 24(1):183. PubMed ID: 32508472
[TBL] [Abstract][Full Text] [Related]
6. Salivary lactate dehydrogenase levels in oral leukoplakia and oral squamous cell carcinoma: a biochemical and clinicopathological study.
Shetty SR; Chadha R; Babu S; Kumari S; Bhat S; Achalli S
J Cancer Res Ther; 2012 Jan; 8 Suppl 1():S123-5. PubMed ID: 22322730
[TBL] [Abstract][Full Text] [Related]
7. Lactate Dehydrogenase as a Biomarker in Oral Submucous Fibrosis: A Systematic Review and Meta-Analysis.
Mahapatra M; Panda A; Kumar H; Barman D; Talukdar R; Dakshinakabat P
Cureus; 2023 Dec; 15(12):e51008. PubMed ID: 38264399
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of Diagnostic Significance of Salivary miRNA-184 and miRNA-21 in Oral Squamous Cell Carcinoma and Oral Potentially Malignant Disorders.
Garg A; Urs AB; Koner BC; Augustine J; Guru SA
Head Neck Pathol; 2023 Dec; 17(4):961-968. PubMed ID: 38015343
[TBL] [Abstract][Full Text] [Related]
9. ABO Blood Groups and Its Association with Oral Cancer, Oral Potentially Malignant Disorders and Oral Submucous Fibrosis- A Systematic Review and Meta-Analysis.
Singh A; Purohit BM
Asian Pac J Cancer Prev; 2021 Jun; 22(6):1703-1712. PubMed ID: 34181324
[TBL] [Abstract][Full Text] [Related]
10. Study of the Role of Salivary Lactate Dehydrogenase in Habitual Tobacco Chewers, Oral Submucous Fibrosis and Oral Cancer as a Biomarker.
Mantri T; Thete SG; Male V; Yadav R; Grover I; Adsure GR; Kulkarni D
J Contemp Dent Pract; 2019 Aug; 20(8):970-973. PubMed ID: 31797856
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of lactate dehydrogenase enzyme activity in saliva and serum of oral submucous fibrosis patients.
Sivaramakrishnan M; Sivapathasundharam B; Jananni M
J Oral Pathol Med; 2015 Jul; 44(6):449-52. PubMed ID: 25224513
[TBL] [Abstract][Full Text] [Related]
12. Comparison of Salivary and Serum Alkaline Phosphates Level and Lactate Dehydrogenase Levels in Patients with Tobacco Related Oral Lesions with Healthy Subjects - A Step Towards Early Diagnosis.
Goyal G
Asian Pac J Cancer Prev; 2020 Apr; 21(4):983-991. PubMed ID: 32334459
[TBL] [Abstract][Full Text] [Related]
13. Salivary lactate dehydrogenase as a prognostic marker in oral squamous cell carcinoma patients following surgical therapy.
Pathiyil V; D'Cruz AM
J Exp Ther Oncol; 2017 Sep; 11(2):133-137. PubMed ID: 28976136
[TBL] [Abstract][Full Text] [Related]
14. Regular clinical follow-up of oral potentially malignant disorders results in improved survival for patients who develop oral cancer.
Jäwert F; Nyman J; Olsson E; Adok C; Helmersson M; Öhman J
Oral Oncol; 2021 Oct; 121():105469. PubMed ID: 34371451
[TBL] [Abstract][Full Text] [Related]
15. Usefulness of protein-based salivary markers in the diagnosis of oral potentially malignant disorders: A systematic review and meta-analysis.
Arroyo E; Donís SP; Petronacci CMC; Alves MGO; Mendía XM; Fernandes D; Pouso AIL; Bufalino A; Bravo López S; Sayáns MP
Cancer Biomark; 2021; 32(4):411-424. PubMed ID: 34334380
[TBL] [Abstract][Full Text] [Related]
16. Assessment of brush biopsy findings and salivary LDH levels in oral mucosal lesions of tobacco users.
Davidson SP; Kumar S; Somasundaram E; Jaishankar S
Indian J Dent Res; 2023; 34(2):191-195. PubMed ID: 37787211
[TBL] [Abstract][Full Text] [Related]
17. Salivary MMP-9 as a Biomarker for the Diagnosis of Oral Potentially Malignant Disorders and Oral Squamous Cell Carcinoma.
Smriti K; Ray M; Chatterjee T; Shenoy RP; Gadicherla S; Pentapati KC; Rustaqi N
Asian Pac J Cancer Prev; 2020 Jan; 21(1):233-238. PubMed ID: 31983189
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic salivary biomarkers in oral cancer and oral potentially malignant disorders and their relationships to risk factors - A systematic review.
Piyarathne NS; Rasnayake RMSGK; Angammana R; Chandrasekera P; Ramachandra S; Weerasekera M; Yasawardene S; Abu-Eid R; Jayasinghe JAP; Gupta E
Expert Rev Mol Diagn; 2021 Aug; 21(8):789-807. PubMed ID: 34148471
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of oral potentially malignant disorders: A systematic review and meta-analysis.
Mello FW; Miguel AFP; Dutra KL; Porporatti AL; Warnakulasuriya S; Guerra ENS; Rivero ERC
J Oral Pathol Med; 2018 Aug; 47(7):633-640. PubMed ID: 29738071
[TBL] [Abstract][Full Text] [Related]
20. Estimation of Salivary and Serum Lactate Dehydrogenase in Oral Submucous Fibrosis.
Mishra S; Kritika C; Bajoria AA; Choudhury P; Sahoo SK; Sangamesh NC
J Int Soc Prev Community Dent; 2018; 8(4):289-295. PubMed ID: 30123759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
